Advaxis, Inc.
Home
About Us
Overview
Management Team
Board of Directors
Partners
Existing Partners
Corporate Presentation
Technology
Lm Technology™
Scientific Publications
Intellectual Property
Scientific Presentations
Pipeline
Axalimogene Filolisbac (ADXS-HPV)
ADXS-PSA
ADXS-HER2
News
Press Releases
In The News
Investors
Overview
Press Releases
News / Events
IR Calendar
Investor Presentations
Videos
Email Alerts
Company Information
Profile
Management Team
IR Contacts
FAQ
Financial Information
Financials
Quarterly Results
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Proxy Statements
Quarterly Reports
Section 16 Filings
Corporate Governance
Board of Directors
Board Committees
Governance Documents
Careers
Contact Us
Email
Advaxis on Facebook
Advaxis on Twitter
Advaxis on LinkedIn
Advaxis on Google+
Advaxis on YouTube+
Advaxis News RSS
Technology
Home
Technology
Scientific Presentations
Technology
Lm Technology™
Scientific Publications
Intellectual Property
Scientific Presentations
Scientific Presentations
Phase I study evaluating high dose ADXS11-001 treatment in women with carcinoma of the cervix
View Presentation Abstract
Back to Scientific Presentations
